Category: biotech

.After antibody-drug conjugate (ADC) expert Seagen was sold to Pfizer in 2013 for a massive $43 billion, former chief executive officer David Epstein mentioned he

.Surrounded by the hereditary medicines arms nationality, Front runner Pioneering is actually revealing a new company to assist biotechs fine-tune the precision of their therapies.The

.Intense Biotech Colleague Editor Gabrielle Masson provided the 2024 course of Tough 15 victors on the floor of the Stock market on Wednesday.Masson seemed on

.Allow’s study a talk with Ayla Ellison, Intense Biotech Editor-in-Chief and also Michelle Benz as they discuss the highlights and enthusiasm neighboring this year’s Tough

.FibroGen is actually drastically restructuring its organization, laying off 75% of its own U.S. personnel and also ceasing assets in its own lead prospect in

.After F2G’s first effort to acquire a new lesson of antifungal to market was actually thwarted due to the FDA, the U.K.-based biotech has secured

.5 months after accepting Power Therapeutics’ Pivya as the initial brand new therapy for simple urinary system tract infections (uUTIs) in more than 20 years,

.The FDA has actually carried out a partial hold on a phase 3 non-small tissue lung cancer cells dry run through BioNTech and OncoC4 after

.The FDA has actually put Kezar Life Sciences’ lupus test on hold after the biotech hailed four deaths in the course of the period 2b

.After dismissing the decision meeting for Applied Rehabs’ metabolic disorder medicine govorestat, the FDA has actually now chosen that a planned advisory committee meeting won’t